loader2
Partner With Us NRI

Max Healthcare Institute Ltd share Price Today

Company details

893.30
915.45
508.50
979.90
6M Return 23.35%
1Y Return 47.83%
Mkt Cap.(Cr) 88,021.21
Volume 730,317
Div Yield 0.16%
OI
-
OI Chg %
-
Volume 730,317

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Healthcare Facilities company Max Healthcare Institute announced Q4FY24 & FY24 results:

  • Consummated transactions for 200 bedded Alexis Hospital, Nagpur and 550 bedded Sahara Hospital, Lucknow, and the results of these hospitals have been consolidated effective Feb 9, 2024 and March 7, 2024 respectively
  • Gross Revenue stood at Rs 1,890 crore for Q4 FY24, growth of 15% YoY & 6% QoQ. This includes Rs 42 crore from two acquired hospitals. On a like-to-like basis, the Gross Revenue grew by 13% YoY and 4% QoQ
  • Network Operating EBITDA was Rs 503 crore, growth of 15% YoY & 7% QoQ. This includes Rs 3 crore (net of deal expenses) from two new hospitals. Accordingly, Network Operating EBITDA from Existing Hospitals stood Rs 500 crore, 14% YoY & 6% QoQ
  • Operating Margin3 on a like-to-like basis stood at 28.4% versus 28.2% in Q4 FY23 and 27.9% in Q3FY24
  • EBITDA per bed4 on a like-to-like basis improved by 12% YoY to Rs 78.5 lakhs in Q4 FY24, from Rs 70.3 lakhs in Q4 FY23 and Rs 75.6 lakhs in Q3 FY24
  • PAT stood at Rs 311 crore in Q4 FY24 Vs Rs 320 crore in Q4 FY23 and Rs 338 crore in Q3 FY24
  • Free Cash from Operations was Rs 412 crore in Q4 FY24. During the quarter, Rs 1,341 crore was spent on acquisition of two hospitals, Rs 176 crore was deployed towards ongoing capacity expansion projects & Rs 168 crore was spent towards purchase of land at Shaheed Path, Lucknow. In addition, Net Cash6 as on Mar 31, 2024 stood at Rs 22 crore
  • Bed occupancy on a like-to-like basisin Q4FY24 stood at 75.1% largely owing to capacity constraints. OBDs were up by ~1% YoY on like-to-like basis and ~5% YoY on overall basis
  • ARPOB on a like-to-like basis improved to Rs 78.1k in Q4 FY24 vs. Rs 70.7k in Q4FY23 and 76.8K in Q3FY24. New hospitals reported an ARPOB of 46.1K
  • Free treatment provided to 35,224 patients in OPD and 1,190 patients in IPD from the economically weaker sections
  • Gross Revenue for the year ended Mar 31, 2024 stood at Rs 7,215 crore, up 16%, Network Operating EBITDA in FY24 was Rs 1,907 crore, an increase of 17%. Operating Margin for FY24 stood at 27.8%

Commenting on Q4 results, Abhay Soi, Chairman and Managing Director, Max Healthcare Institute Ltd., said: “We are happy to consummate two long drawn inorganic deals during the quarter. These transactions add significant capacity going forth and allow for additional brownfield opportunities in the fastgrowing markets of UP & Maharashtra. The existing hospital network is consistently improving its performance and generating stable cashflows, enabling us to look for more inorganic opportunities while we expand the existing capacities.”

Result PDF

View Other Company Results

Max Healthcare Institute Ltd shares SWOT Analysis

Strengths (5)

  • Effectively using its capital to generate profit - RoCE improving in last 2 years
  • Company with Low Debt
  • Book Value per share Improving for last 2 years

Weakness (3)

  • Negative Breakdown First Support (LTP < S1)
  • MFs decreased their shareholding last quarter
  • Declining Net Cash Flow : Companies not able to generate net cash

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • Promoter decreasing their shareholding
  • High PE (PE > 40)

Resistance and support

R1 928.7
R2 936.4
R3 946.5
Pivot

918.60

S1 910.9
S2 900.8
S3 893.1
EMA SMA
904.6
871.3
830.9
762.2
915.5
858.5
827.7
748.3
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
GOVERNMENT OF SINGAPORE Bulk Purchase 2023-05-31 549.53 6660226 NSE
BNP PARIBAS ARBITRAGE Bulk Purchase 2023-05-31 546.08 20946 NSE
BNP PARIBAS ARBITRAGE Bulk Sell 2023-05-31 546.56 9033634 NSE
Name Category Shares
Abhay Soi PROMOTER 23.74%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Max Healthcare Institute Ltd Stocks COMPARISON

Financials( in Cr) Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Fortis Healthcare Ltd Global Health Ltd Narayana Hrudayalaya Ltd
Price 905.65 6,474.70 485.50 1,202.85 1,242.30
% Change -0.21 1.55 3.28 -3.95 1.40
Mcap Cr 88,021.21 93,096.47 36,653.21 32,297.36 25,387.77
Revenue TTM Cr 4,831.37 16,612.50 7,175.67 2,280.01 4,524.77
Net Profit TTM Cr 1,103.51 887.50 645.22 360.89 606.57
PE TTM 84.60 103.43 63.18 67.87 32.20
1 Year Return 47.83 25.52 50.47 73.41 22.06
ROCE 13.85 14.16 9.65 17.19 29.27
ROE 16.12 15.04 7.81 13.52 33.51
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 7,409.54 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 21,424.68 50,451.86
LAST 3M 100,072.29 51,097.20
LAST 6M 183,053.48 43,859.44
LAST 12M 309,832.68 84,987.81

Max Healthcare Institute Ltd Information

Stock PE (TTM)
84.6
Promoter Holding
23.75%
Book Value
86.5113
ROCE
13.85%
ROE
16.12%
Description
  • Max Healthcare Institute Limited is an India-based healthcare company with a market capitalisation of Rs. 35,729.35 crore as of April 5, 2022. It owns and operates hospital chains across Delhi, National Capital Region (NCR), North India, and Mumbai. The company was incorporated on June 18, 2001, and its revenue touched Rs. 2,505 crore in the financial year 2021-22. Max Healthcare shares are listed on the Bombay Stock Exchange (BSE) as well as the National Stock Exchange (NSE) under the number 543220 and scrip code MAXHEALTH, respectively.

    Max Healthcare Limited is an Indian company that runs a chain of hospitals that specialise in providing treatment for cancer, oncology, neurosciences, cardiac sciences, orthopaedics, liver transplant, kidney transplant, bone marrow transplant, nephrology, and laparoscopic surgery, among others. The company also provides pathology and diagnostic services to its patients through a variety of channels, including self-owned and third-party diagnostic centres. The majority of Max Healthcare hospitals are located in Delhi, the National Capital Region (NCR), northern parts of India, and western Mumbai.

    The company was founded in 2000 and its first hospital was opened in the same year in South Delhi’s Panchsheel Park. It opened two more hospitals in 2002 in Northwest Delhi and Eastern Delhi. In 2011, Max Healthcare Limited signed a public-private partnership agreement with the government of Punjab to set up two hospitals in Mohali and Bathinda. It witnessed acquisitions and mergers with several hospitals during the process, including Pushpanjali Crosslay Hospital in Vaishali, Saket City Hospital in Saket, Radiant Lifecare, and the iconic Nanavati Hospital in Mumbai, and soon became the second-largest healthcare company in India in terms of revenues. The total number of employees of this company stood at 3,783 in 2020. The Managing Director of the company, Abhay Soi, holds 23.1% shares in the company, other promoters 37.54%, FII investors 16.67%, public investors 6.97%, and 15.58% are invested in mutual funds.

    As of April 5, 2022, Max Healthcare’s share price closed at Rs. 369.40 at the NSE. The 52-week high for Max Health share is Rs. 458.05 and the 52-week low is Rs. 212.00. Max Healthcare shares have provided one-year returns of 61.06%.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code :07730), BSE Ltd (Member Code :103) and Member of Multi Commodity Exchange of India Ltd. (Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

167 Floor-1 Plot-167, Ready Money Mansion Worli, Mumbai, Maharashtra, 400018

Tel : 91-22-66604447/48/49
Email : investors:maxhealthcare.com
Website : http://www.maxhealthcare.in
Registrar

Link Intime India Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 543220
NSE Code : MAXHEALTH
Book Closure Date (Month) :
BSE Group : A
ISIN : INE027H01010

FAQ’s on Max Healthcare Institute Ltd Shares

You can buy Max Healthcare Institute Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Max Healthcare Institute Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 18, 2024 12:39 PM the closing price of Max Healthcare Institute Ltd was Rs.905.65.

The latest PE ratio of Max Healthcare Institute Ltd as of Jul 18, 2024 12:39 PM is 84.60

The latest PB ratio of Max Healthcare Institute Ltd as of Jul 18, 2024 12:39 PM is 0.09

The 52-week high of Max Healthcare Institute Ltd share price is Rs. 979.90 while the 52-week low is Rs. 508.50

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 18, 2024 12:39 PM, the market cap of Max Healthcare Institute Ltd stood at Rs. 88,021.21 Cr.

Download App

Download Our App

Play Store App Store
market app